Abstract
purpose. To evaluate the relationship between retinal ganglion cell (RGC) size, density distribution, and survival in senescent DBA2/NNia mice that develop pigmentary glaucoma. To evaluate the validity of nearest neighbor distance (NND), a measure of focal density for surviving RGCs in the retina, as a method to quantify RGC loss in mice.
methods. Fifteen-month-old DBA2/NNia mice were labeled retrogradely with fluorogold. Retinas were flat mounted and imaged in their entirety using an epifluorescence microscope with a motorized stage. Digital maps of the retinal wholemounts were constructed to automatically count and establish spatial coordinates for RGCs over the entire retina. RGC size and NND were determined from these maps.
results. RGC counts in the group of 15-month-old DBA/2NNia animals ranged from 22,330 to 92,157 cells per retina. Mean RGC cell size per retina ranged from 22.35 to 35.64 μm2 and correlated linearly with total RGC counts. NND distribution histograms were compared for retinas with variable degrees of RGC loss. The distribution of NNDs in each retina was skewed toward larger distance values in more affected retinas. In partially damaged retinas, areas with severe pathology coincided with areas of maximal loss of large RGCs, and areas of preserved RGCs correlated with larger cell sizes.
conclusions. Damaged retinas have a smaller mean cell size, indicating preferential loss of larger RGCs or size reduction of surviving cells. NND analysis of the RGC population in a retina is a useful measure of glaucomatous RGC loss. The skewed NND distribution of surviving RGCs and the finding that RGC loss correlates with a shift/amplitude change in the mode of the histogram and its tail suggests two different patterns of RGC loss possibly attributable to different pathologic processes in glaucomatous DBA/2 mice.
Induced glaucoma models in the rat have been the subject of increasing research interest in recent years
1 2 3 4 5 and have been used to evaluate substances with potential neuroprotective or antiapoptotic properties.
6 7 8 9 10 These models exhibit a range of pathology, most likely because of the diverse characteristics and the severity and duration of the surgical insult used to induce IOP elevation.
More recently, murine models of glaucomatous optic neuropathy have also become of interest to some investigators.
11 12 13 14 15 16 Highly inbred mouse strains have a more restricted biologic variability that, together with spontaneous or gene-induced development of high IOP,
11 12 17 18 19 makes them desirable glaucoma models for investigation. Other potentially important examples for glaucoma research are mice with gene knockouts of components of the apoptotic cell death program of neurons,
20 21 which is thought to be the primary mechanism for retinal ganglion cell (RGC) loss in glaucoma. A critical requirement in most studies of mouse glaucoma models is the quantification of RGC somata or their axons.
Automated counting methods to quantify RGC loss in the glaucomatous retina have certain advantages over manual counting based on sampling.
22 The assessment of RGCs in virtually 100% of the retinal area provides increased counting precision and allows the investigation of spatial and cell size patterns of surviving RGCs in a retina with glaucoma. In this study, we examined the detailed spatial arrangement and the cell size of RGCs in murine retinas with different degrees of glaucomatous RGC loss. We used an automated counting method to quantify the glaucomatous focal RGC loss encountered in aged DBA/2NNia mice.
16 The spontaneous development of secondary glaucoma in this mouse strain is partially age and sex dependent and results from gene mutations causing iris atrophy and pigment dispersion,
12 together with an immunologic component,
23 that is not yet fully understood. Therefore, individual eyes in a nonselected, mixed-sex population of DBA/2 mice of the same age can exhibit a range of retinal pathology. We used such a group of mice at 15 months of age to study the patterns of RGC survival in retinas with varying degrees of glaucomatous neuropathy. We created data libraries of the studied retinas and digitally constructed spatial RGC maps to extend the analysis from cell counts to morphologic and topographic associations of surviving RGCs. To further characterize the previously reported spatial non-uniformity of RGC loss,
16 we investigated the use of nearest neighbor distance (NND) for every RGC in a retina as a measure of focal RGC density. NND is defined as the distance between the centroid of each RGC and the centroid of its closest neighbor. The centroid is defined as the moment center for each object and can be calculated for any object, symmetric or asymmetric. It corresponds to its geometric center for a symmetric object. NND and the spatial coordinates of the centroid for each object in a binary image are directly provided by a plug-in of Photoshop 5.5 (Adobe, San Jose, CA).
24 Consequently, for each cell, the NND approximates the radius of a circular retinal area occupied by that cell alone. NND is thus inversely related to RGC density and is independent of the constraints inherent in density analysis of RGCs calculated from sampling frames. Therefore, the NND approach has potential advantages for quantifying and characterizing the overall RGC loss in a retina compared with gross RGC counts estimated from sampling or frame cell density analysis.
Digital data libraries were created for each retina; every counted object was represented by its position coordinates and contained information on object size, object symmetry, and relationship to adjacent objects. Software (Photoshop 5.5; Adobe) was used to record the spatial coordinates of the moment center (centroid) of each object in the converted black-and-white binary images that represented the RGCs imaged on the epifluorescence microscope,
16 22 along with other information such as equivalent cell diameter and symmetry (function: measure all in Photoshop 5.5; Adobe). One of these measures is NND, defined as centroid-to-centroid distance of one object to its closest neighbor.
24 We also constructed retinal NND maps of all eight retinas studied by plotting the spatial coordinates of each object (RGC) and its corresponding NND value in statistical analysis software (NCSS, Kaysville, UT).
Finally, from the same data libraries, we calculated a mean object size, reflected by its area, for all objects (RGCs) and correlated this value with the total RGC counts. Pixel size for an object was converted (Photoshop 5.5; Adobe) to a circular area of equivalent diameter providing, in this case, an estimate of RGC size (function: measure all in Photoshop 5.5; Adobe).
The eight retinas of the 15-month-old DBA/2NNia mice showed a great degree of variability in pathology, with total counts of surviving RGCs ranging between 22,330 and 92,157 cells. The mean (± SD) count for the group was 49,849.5 ± 27,397 cells. There was no statistically significant difference between right and left eyes: 50,173.6 ± 24,688.8 and 49,399.1 ± 37,463.7 cells, respectively (P = 0.97; Student t test). The average retinal area for the group was 20 ± 1.3 mm2, and the average cell density was 2497 ± 1388 RGCs/mm2. However, these numerical values do not illustrate the wide range of RGC loss encountered in this group of 15-month-old DBA2/NNia retinas.
Aged DBA/2NNia mice can show considerable variability with respect to retinal ganglion cell loss within an age group despite the fact that they are an inbred strain. Some eyes in 15-month-old animals can have near normal RGC counts, similar to those of unaffected mice at 3 months of age.
16 Part of this variability may be related to the variability in IOP among individual eyes
16 or to sex differences. Alternative ways to analyze labeled RGCs can potentially increase our ability to quantify RGC loss beyond measures of total RGC counts.
As illustrated here, automated counting methods may allow for easier extraction of detailed information about RGCs than sampling and manual counting routines. Information that can be obtained from digital images includes not only total RGC counts per retina but also estimates of local density, cell size, and shape information that allows mapping of RGC loss and survival anywhere in the retina.
NND analysis provides an alternative measure to quantify RGC loss and has the capability to differentiate more uniformly distributed cell loss from the patchy, non-uniform type of loss typical of glaucoma. NND has conceptual homologies to the inverse of the focal cell density calculated for each individual cell and thus does not depend on averaging effects when cells are counted in a representative area (frame) of the retina. As with density, NND defined as centroid-to-centroid distance is affected to some extent by cell size. Despite this limitation, we reasoned that NND might be better able to differentiate between focal and more uniformly distributed RGC loss within each retina, thus providing a better way to model the pattern of RGC loss and allowing comparisons between retinas. Diffuse loss would manifest as a shift of the NND distribution to the right, whereas focal loss would appear as an increase in the proportion of cells with very large NNDs. The NND distribution analysis indicates that both types of loss appear to take place simultaneously in the DBA/2 mouse model of glaucomatous optic neuropathy, suggesting that there may be two pathologic processes leading to RGC depletion in this model of glaucoma. Our findings validate the use of NND as a useful tool for detecting focal and diffuse RGC loss. Examining the effect of the neuroprotective agents/inhibitors of the apoptotic pathway on the distribution characteristics of the NND, as shown in
Figure 3 , could provide a means to differentiate effects on diffuse or focal RGC loss. Finally, NND analysis can be used to compare different glaucoma models and to provide indications of the type of RGC pathology these models cause in relation to the duration and severity of the insult. An additional important advantage is that NND analysis for a group of retinas provides an overall measure of disease that is less dependent on biologic variability and potential inaccuracies than the single number of a total RGC count derived from manual or automated counting and may prove itself to be more sensitive in detecting early glaucomatous loss. Therefore, the increased statistical power for comparisons of NND distributions may significantly increase our ability to screen for effective treatments that preserve RGCs.
Cell size analysis is an additional capability offered by the construction of digital libraries of all the retrogradely labeled objects (RGCs) within each retina. The large number of RGCs counted by automated methods can overcome shortcomings in accuracy of the absolute cell size compared with more precise estimates derived from a few RGCs in limited areas of the retina captured under high magnification. In the present study, occasional underestimation or overestimation of RGC size because of depth-of-field variations in the captured images or merged cells appears to be random and does not make cell size comparison among retinas any less valid. This conclusion is based on the finding that correlations between cell size and cell loss in the data presented were not affected when the databases were filtered from grossly asymmetric objects representing artifacts or merging of more than one cell (data not shown). The filtering process resulted in the removal of less than 1.5% of the objects and only minimally affected the absolute values of cell sizes and their distribution.
Mean cell size, estimated from the area of the imaged RGCs, in affected retinas of senescent DBA/2 animals appears to be 15% to 20% smaller than in undamaged retinas and results from relative depletion of larger RGCs compared with smaller ones or from cell shrinkage. Larger cells also appear to be located on islands of preserved RGCs within affected retinas. This finding is in agreement with reports that ocular hypertension is associated with an overall size reduction in RGCs in monkey, cat, and rat glaucoma models (Cordeiro MF, et al.
IOVS 2004;45:ARVO E-Abstract 1114; Guo L, et al.
IOVS 2004;45:ARVO E-Abstract 2153),
28 29 30 31 32 and has recently been reported to also occur in a rat glaucoma model.
33 The degree of overall cell size reduction in the DBA/2 retina is within the range reported for
Macaca fascicularis monkeys after 6 to 14 weeks of ocular hypertension.
34 In this study, we present new evidence of spatial correlation between larger cell size and areas of RGC preservation. This result implies the converse, namely that in those areas of a glaucomatous retina in which extensive RGC loss occurs, the largest cells die, or, if they survive, they shrink. Our data, however, could not indicate whether smaller RGCs are less susceptible to injury or whether RGCs in the glaucomatous retina tend to shrink before cell death. Nevertheless our findings show that cell size distribution analysis can provide another measure of the extent of disease in the glaucomatous retina.
In summary, our data confirm the usefulness of automated RGC counting as a method for evaluating glaucomatous retinal damage. Measures of RGC distribution, such as NND, and RGC size can improve our understanding of the pathophysiology of the disease and increase the power of experimental studies. RGC distribution characteristics, such as NND, and RGC cell size complement RGC total cell number as a method of quantifying RGC cell loss in a glaucoma model and offer a more complete description of the disease in the RGC layer. Application of these additional measures of RGC loss may help overcome some of the problems caused by the variability encountered in many glaucoma models.
Supported by the Kriezis Foundation; National Institutes of Health Grants R01 EY13399, NEI K08 00390, R01 EY015224, EY13467, EY01867; Research to Prevent Blindness; and the Fund for Ophthalmic Knowledge.
Submitted for publication July 22, 2005; revised November 19, 2005; accepted March 13, 2006.
Disclosure:
T. Filippopoulos, None;
J. Danias, None;
B. Chen, None;
S.M. Podos, None;
T.W. Mittag, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Theodoros Filippopoulos, Department of Ophthalmology, Brown University Medical School, APC 7th, 593 Eddy Street, Providence, RI 02903;
[email protected].
The authors thank Nikolaos K. Robakis (Mount Sinai School of Medicine, New York, NY) for making the Axioskop 2 (Zeiss) available.
ShareefSR, Garcia-ValenzuelaE, SaliernoA, et al. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res. 1995;61:379–382.
[CrossRef] [PubMed]VorwerkCK, LiptonSA, ZurakowskiD, et al. Chronic low-dose glutamate is toxic to retinal ganglion cells: toxicity blocked by memantine. Invest Ophthalmol Vis Sci. 1996;37:1618–1624.
[PubMed]MorrisonJC, MooreCG, DeppmeierLM, et al. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85–96.
[CrossRef] [PubMed]LaquisS, ChaudharyP, SharmaSC. The patterns of retinal ganglion cell death in hypertensive eyes. Brain Res. 1998;784:100–104.
[CrossRef] [PubMed]MittagTW, DaniasJ, PohorenecG, et al. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2000;41:3451–3459.
[PubMed]NeufeldAH, SawadaA, BeckerB. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA. 1999;96:9944–9948.
[CrossRef] [PubMed]GuZ, YamamotoT, KawaseC, et al. Neuroprotective effect of
N-methyl-D-aspartate receptor antagonists in an experimental glaucoma model in the rat. [in Japanese]Nippon Ganka Gakkai Zasshi. 2000;104:11–16.
[PubMed]WheelerLA, GilDW, WoldeMussieE. Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma. Surv Ophthalmol. 2001;45(suppl 3)S290–S294; discussion S5–S6.
[CrossRef] [PubMed]NeufeldAH, DasS, VoraS, et al. A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma. J Glaucoma. 2002;11:221–225.
[CrossRef] [PubMed]HuangW, FiletaJB, DobberfuhlA, et al. Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proc Natl Acad Sci USA. 2005;102:12242–12247.
[CrossRef] [PubMed]SheldonWG, WarbrittonAR, BucciTJ, TurturroA. Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab Anim Sci. 1995;45:508–518.
[PubMed]JohnSW, SmithRS, SavinovaOV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951–962.
[PubMed]Levkovitch-VerbinH, Harris-CerrutiC, GronerY, et al. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci. 2000;41:4169–4174.
[PubMed]SchuettaufF, QuintoK, NaskarR, ZurakowskiD. Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model. Vision Res. 2002;42:2333–2337.
[CrossRef] [PubMed]AiharaM, LindseyJD, WeinrebRN. Experimental mouse ocular hypertension: establishment of the model. Invest Ophthalmol Vis Sci. 2003;44:4314–4320.
[CrossRef] [PubMed]DaniasJ, LeeKC, ZamoraMF, et al. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthalmol Vis Sci. 2003;44:5151–5162.
[CrossRef] [PubMed]ChangB, SmithRS, HawesNL, et al. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet. 1999;21:405–409.
[CrossRef] [PubMed]AndersonMG, SmithRS, SavinovaOV, et al. Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice. BMC Genet. 2001;2:1.
[PubMed]AiharaM, LindseyJD, WeinrebRN. Ocular hypertension in mice with a targeted type I collagen mutation. Invest Ophthalmol Vis Sci. 2003;44:1581–1585.
[CrossRef] [PubMed]BonfantiL, StrettoiE, ChierziS, et al. Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2. J Neurosci. 1996;16:4186–4194.
[PubMed]PennesiME, ChoJH, YangZ, et al. BETA2/NeuroD1 null mice: a new model for transcription factor-dependent photoreceptor degeneration. J Neurosci. 2003;23:453–461.
[PubMed]DaniasJ, ShenF, GoldblumD, et al. Cytoarchitecture of the retinal ganglion cells in the rat. Invest Ophthalmol Vis Sci. 2002;43:587–594.
[PubMed]MoJS, AndersonMG, GregoryM, et al. By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA/2J pigmentary glaucoma. J Exp Med. 2003;197:1335–1344.
[CrossRef] [PubMed]RussJC. The Image Processing Handbook. 1998; 3rd ed.CRC Press Boca Raton, FL.
BayerAU, NeuhardtT, MayAC, et al. Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma. Invest Ophthalmol Vis Sci. 2001;42:1258–1265.
[PubMed]FranklinTR, DruhanJP. The retrograde tracer fluoro-gold interferes with the expression of fos-related antigens. J Neurosci Methods. 2000;98:1–8.
[CrossRef] [PubMed]PaxinosG, FranklinKBJ. The mouse brain in stereotaxic coordinates. 2001;Academic Press San Diego.
GlovinskyY, QuigleyHA, DunkelbergerGR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 1991;32:484–491.
[PubMed]GlovinskyY, QuigleyHA, PeaseME. Foveal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 1993;34:395–400.
[PubMed]WeberAJ, KaufmanPL, HubbardWC. Morphology of single ganglion cells in the glaucomatous primate retina. Invest Ophthalmol Vis Sci. 1998;39:2304–2320.
[PubMed]ShouT, LiuJ, WangW, et al. Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Invest Ophthalmol Vis Sci. 2003;44:3005–3010.
[CrossRef] [PubMed]CordeiroMF, GuoL, LuongV, et al. Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci USA. 2004;101:13352–13356.
[CrossRef] [PubMed]DaniasJ, ShenF, KavalarakisM, et al. Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model. Exp Eye Res. 2006;82:219–228.
[CrossRef] [PubMed]MorganJE, UchidaH, CaprioliJ. Retinal ganglion cell death in experimental glaucoma. Br J Ophthalmol. 2000;84:303–310.
[CrossRef] [PubMed]